dermalera-3 · L3 - Massage · Coral Gables (Southeast)
Current Option Inventory (Units and GB are quarter-to-date rollups from 2026-04-01)
| Option | List | Sell | Effective Margin | Units QTD | GB QTD |
|---|---|---|---|---|---|
| 5 Massages w/Foot Reflexology - 60 Minutes (Full Body, Deep Tissue, Lymphatic) | $874.95 | $445.00 | 0.0% | 0 | $0.00 |
| Two 60-Minute Massages with Foot Reflexology | $350.00 | $189.00 | 0.0% | 0 | $0.00 |
| 1 Massage w/Foot Reflexology - 60 Minutes (Full Body, Deep Tissue, Lymphatic) | $174.99 | $110.00 | 0.0% | 0 | $0.00 |
| 3 Massages w/Foot Reflexology - 60 Minutes (Full Body, Deep Tissue, Lymphatic) | $525.03 | $279.00 | 26.5% | 1 | $279.00 |
| Four 60-Minute Massages with Foot Reflexology | $700.02 | $375.00 | 0.0% | 0 | $0.00 |
Activity Timeline (sorted newest first)
- 2025-09-01 Margin change on 3 Massages w/Foot Reflexology - 60 Minutes (Full Body, Deep Tissue, Lymphatic) — 30.8% → 26.5% analysed below
- 2025-04-01 Margin change on 3 Massages w/Foot Reflexology - 60 Minutes (Full Body, Deep Tissue, Lymphatic) — 34.8% → 30.8%
- 2025-03-01 Margin change on 1 Massage w/Foot Reflexology - 60 Minutes (Full Body, Deep Tissue, Lymphatic) — 40.9% → 30.0% analysed below
3-Comparison — 1 Massage w/Foot Reflexology - 60 Minutes (Full Body, Deep Tissue, Lymphatic) dermalera-3
Margin: 40.9% → 30.0% (-10.9pp)
Windows: 30 days before change, 30 days after, same period last year, and peer-cohort change. "Δ vs Peer" is market-relative: deal's before→after change minus peers' before→after change. Positive = deal outperformed market. Negative = peers improved more than the deal did.
| Metric | Before 30d | After 30d | Δ vs Before | YoY | Δ vs YoY | Peer Δ (bf→after) | Δ vs Peer | Verdict |
|---|---|---|---|---|---|---|---|---|
| CVR | 2.3% | 2.9% | +23.9% | 0.0% | n/a | -11.9% | +35.8% | inconclusive |
| GB/UDV | $2.54 | $3.14 | +23.9% | $0.00 | n/a | -13.1% | +37.0% | |
| MVR/UDV | $0.80 | $0.70 | -12.1% | $0.00 | n/a | -63.6% | +51.6% |
3-Comparison — 3 Massages w/Foot Reflexology - 60 Minutes (Full Body, Deep Tissue, Lymphatic) dermalera-3
Margin: 30.8% → 26.5% (-4.3pp)
Windows: 30 days before change, 30 days after, same period last year, and peer-cohort change. "Δ vs Peer" is market-relative: deal's before→after change minus peers' before→after change. Positive = deal outperformed market. Negative = peers improved more than the deal did.
| Metric | Before 30d | After 30d | Δ vs Before | YoY | Δ vs YoY | Peer Δ (bf→after) | Δ vs Peer | Verdict |
|---|---|---|---|---|---|---|---|---|
| CVR | 0.0% | 0.2% | n/a | 0.0% | n/a | +5.0% | n/a | insufficient data |
| GB/UDV | $0.00 | $0.42 | n/a | $0.00 | n/a | -2.7% | n/a | |
| MVR/UDV | $0.00 | $0.07 | n/a | $0.00 | n/a | -1576.2% | n/a |
SF Context
Churn-threat classification from sales cases and tasks: sf data insufficient
No churn-threat keywords detected in recent cases or tasks.